Medpace Holdings [MEDP] vs Agilent Technologies [A] Detailed Stock Comparison

Medpace Holdings

NASDAQ
Loading...

Agilent Technologies

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Medpace Holdings wins in 6 metrics, Agilent Technologies wins in 13 metrics, with 0 ties. Agilent Technologies appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMedpace HoldingsAgilent TechnologiesBetter
P/E Ratio (TTM)39.5633.02Agilent Technologies
Price-to-Book Ratio86.576.31Agilent Technologies
Debt-to-Equity Ratio86.9356.42Agilent Technologies
PEG Ratio3.641.53Agilent Technologies
EV/EBITDA29.7422.97Agilent Technologies
Profit Margin (TTM)18.74%17.97%Medpace Holdings
Operating Margin (TTM)20.94%23.19%Agilent Technologies
EBITDA Margin (TTM)20.94%23.19%Agilent Technologies
Return on Equity89.39%19.88%Medpace Holdings
Return on Assets (TTM)17.09%8.35%Medpace Holdings
Free Cash Flow (TTM)$572.27M$1.37BAgilent Technologies
Dividend YieldN/A0.85%N/A
1-Year Return52.42%-1.54%Medpace Holdings
Price-to-Sales Ratio (TTM)6.705.92Agilent Technologies
Enterprise Value$15.06B$42.21BAgilent Technologies
EV/Revenue Ratio6.756.22Agilent Technologies
Gross Profit Margin (TTM)29.84%51.09%Agilent Technologies
Revenue per Share (TTM)$74$24Medpace Holdings
Earnings per Share (Diluted)$13.46$4.29Medpace Holdings
Beta (Stock Volatility)1.411.26Agilent Technologies
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Medpace Holdings vs Agilent Technologies Stock Performance Analysis

Loading Price Chart...

Medpace Holdings
Agilent Technologies
Medpace Holdings Stock Overview | Agilent Technologies Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings-0.41%5.90%7.76%66.29%82.80%58.42%
Agilent Technologies-0.02%14.43%10.52%18.75%36.70%6.13%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings52.42%246.47%328.56%1,791.23%1,791.23%1,791.23%
Agilent Technologies-1.54%12.66%32.72%295.78%474.25%540.19%

News Based Sentiment: Medpace Holdings vs Agilent Technologies

Medpace Holdings

News based Sentiment: MIXED

Medpace is showing strong financial performance with increased institutional investment and positive guidance, but faces a recent analyst downgrade and a relatively high valuation. The combination of positive and negative developments creates a mixed investment picture for the month.

View Medpace Holdings News Sentiment Analysis

Agilent Technologies

News based Sentiment: POSITIVE

Agilent delivered a strong Q3 earnings report, exceeding revenue expectations and receiving multiple analyst upgrades and price target increases. Strategic partnerships and continued innovation further strengthen the investment case, indicating a positive trajectory for the company.

View Agilent Technologies News Sentiment Analysis

Performance & Financial Health Analysis: Medpace Holdings vs Agilent Technologies

MetricMEDPA
Market Information
Market Cap i$14.96B$40.16B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i278,9801,888,910
90 Day Avg. Volume i314,9431,942,390
Last Close$530.30$141.61
52 Week Range$250.05 - $547.15$96.43 - $153.84
% from 52W High-3.08%-7.95%
All-Time High$547.15 (Oct 01, 2025)$179.57 (Aug 30, 2021)
% from All-Time High-3.08%-21.14%
Growth Metrics
Quarterly Revenue Growth0.14%0.10%
Quarterly Earnings Growth0.02%0.19%
Financial Health
Profit Margin (TTM) i0.19%0.18%
Operating Margin (TTM) i0.21%0.23%
Return on Equity (TTM) i0.89%0.20%
Debt to Equity (MRQ) i86.9356.42
Cash & Liquidity
Book Value per Share (MRQ)$6.15$22.46
Cash per Share (MRQ)$1.65$5.41
Operating Cash Flow (TTM) i$614.10M$1.50B
Levered Free Cash Flow (TTM) i$445.14M$902.88M
Dividends
Last 12-Month Dividend Yield iN/A0.85%
Last 12-Month Dividend iN/A$0.98

Valuation & Enterprise Metrics Analysis: Medpace Holdings vs Agilent Technologies

MetricMEDPA
Price Ratios
P/E Ratio (TTM) i39.5633.02
Forward P/E i42.6325.07
PEG Ratio i3.641.53
Price to Sales (TTM) i6.705.92
Price to Book (MRQ) i86.576.31
Market Capitalization
Market Capitalization i$14.96B$40.16B
Enterprise Value i$15.06B$42.21B
Enterprise Value Metrics
Enterprise to Revenue i6.756.22
Enterprise to EBITDA i29.7422.97
Risk & Other Metrics
Beta i1.411.26
Book Value per Share (MRQ) i$6.15$22.46

Financial Statements Comparison: Medpace Holdings vs Agilent Technologies

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MEDPA
Revenue/Sales i$558.57M$1.67B
Cost of Goods Sold i$380.22M$802.00M
Gross Profit i$178.35M$866.00M
Research & Development iN/A$112.00M
Operating Income (EBIT) i$113.52M$300.00M
EBITDA i$120.45M$362.00M
Pre-Tax Income i$118.17M$260.00M
Income Tax i$3.58M$45.00M
Net Income (Profit) i$114.60M$215.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MEDPA
Cash & Equivalents i$441.44M$1.49B
Total Current Assets i$821.44M$4.21B
Total Current Liabilities i$1.12B$2.01B
Long-Term Debt i$126.66M$3.35B
Total Shareholders Equity i$593.61M$6.14B
Retained Earnings i$-269.72M$912.00M
Property, Plant & Equipment i$258.19MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MEDPA
Operating Cash Flow i$166.55M$178.00M
Capital Expenditures i$-9.99M$-114.00M
Free Cash Flow i$115.84M$107.00M
Debt Repayment iN/A$0
Common Stock Repurchase i$-371.90M$-165.00M

Short Interest & Institutional Ownership Analysis

MetricMEDPA
Shares Short i2.20M3.20M
Short Ratio i6.811.81
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i278,9801,888,910
Average Daily Volume (90 Day) i314,9431,942,390
Shares Outstanding i30.63M285.19M
Float Shares i22.25M282.49M
% Held by Insiders i0.21%0.00%
% Held by Institutions i0.97%0.93%

Dividend Analysis & Yield Comparison: Medpace Holdings vs Agilent Technologies

MetricMEDPA
Last 12-Month Dividend iN/A$0.98
Last 12-Month Dividend Yield iN/A0.85%
3-Year Avg Annual Dividend iN/A$0.86
3-Year Avg Dividend Yield iN/A0.18%
3-Year Total Dividends iN/A$2.57
Ex-Dividend DateN/AApr 01, 2025